University of Health Sciences, Konya City Hospital
Konya, 42020, Turkey (Türkiye)
NCT Number: NCT07585435
The purpose of this study is to investigate the effect of different salt concentrations (tonicity) in the coupling fluid used during Extracorporeal Shock Wave Lithotripsy (ESWL). The study compares three types of coupling fluids: hypotonic (degassed water), isotonic (0.9% NaCl), and hypertonic (3% NaCl) solutions. Researchers aim to determine which solution provides the best stone fragmentation success while minimizing procedure-related pain and skin complications.
Looking for future studies?
Notify Me18 year and older
All sexes
Interventional
Not applicable
Konya, 42020, Turkey (Türkiye)
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Patients with kidney stones measuring 5-20 mm.
Patients scheduled for ESWL treatment.
Age 18 and older
Exclusion criteria
Pregnancy.
Uncorrected bleeding disorders.
Active urinary tract infection.
Anatomical abnormalities preventing ESWL.
Hypotonic degassed water was used as the coupling fluid during the ESWL procedure.
0.9% NaCl (isotonic) solution was used as the coupling fluid during the ESWL procedure.
3% NaCl (hypertonic) solution was used as the coupling fluid during the ESWL procedure.
Time frame: 2-4 weeks after the ESWL procedure
The percentage of patients achieving successful stone fragmentation, defined as residual fragments smaller than 4 mm.
Time frame: Immediately after the ESWL procedure
Pain intensity assessed using the Visual Analog Scale (VAS), where 0 represents no pain and 10 represents the worst imaginable pain.
Konya City Hospital
Other
Acoustic Impedance Matching in ESWL: A Comparative Analysis of Hypotonic, Isotonic and Hypertonic Coupling Fluids
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT02214836
Calculi, Female Urogenital Diseases
Seattle, Washington, United States
View Trial DetailsNCT07159035
Calculi, Female Urogenital Diseases
Guangzhou, Guangdong, China
View Trial DetailsNCT07377461
Calculi, Female Urogenital Diseases
Ashkelon, Israel
View Trial DetailsNCT01835600
Calculi, Female Urogenital Diseases
Shanghai, Shanghai Municipality, China
View Trial Details